Financial report interval: 2025.12.31 - 2026.03.31
Preview: Connect Biopharma(CNTB) predict that the Revenue is 1.148 M (--%), Beat estimate;the EBIT is -133.23 M (-61.48%), Miss estimate;the EPS is -0.34 (-78.95%), Miss estimate.